Dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development

Abstract COVID‐19 should be considered as a new triggering factor for autoimmune disorders like DM‐lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID‐19.

Guardado en:

Detalles Bibliográficos
Autores principales:	Mohammad Shahidi Dadras, Azadeh Rakhshan, Arman Ahmadzadeh, Seyed Ali Hosseini, Reem Diab, Toktam Safari Giv, Fahimeh Abdollahimajd
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	COVID‐19 dermatomyositis lupus erythematosus myositis trigger Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/e356d883bbcc4adb9951d5b0c93059f0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e356d883bbcc4adb9951d5b0c93059f0
record_format	dspace
spelling	oai:doaj.org-article:e356d883bbcc4adb9951d5b0c93059f02021-12-02T07:55:56ZDermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development2050-090410.1002/ccr3.4931https://doaj.org/article/e356d883bbcc4adb9951d5b0c93059f02021-10-01T00:00:00Zhttps://doi.org/10.1002/ccr3.4931https://doaj.org/toc/2050-0904Abstract COVID‐19 should be considered as a new triggering factor for autoimmune disorders like DM‐lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID‐19.Mohammad Shahidi DadrasAzadeh RakhshanArman AhmadzadehSeyed Ali HosseiniReem DiabToktam Safari GivFahimeh AbdollahimajdWileyarticleCOVID‐19dermatomyositislupus erythematosusmyositistriggerMedicineRMedicine (General)R5-920ENClinical Case Reports, Vol 9, Iss 10, Pp n/a-n/a (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID‐19 dermatomyositis lupus erythematosus myositis trigger Medicine R Medicine (General) R5-920
spellingShingle	COVID‐19 dermatomyositis lupus erythematosus myositis trigger Medicine R Medicine (General) R5-920 Mohammad Shahidi Dadras Azadeh Rakhshan Arman Ahmadzadeh Seyed Ali Hosseini Reem Diab Toktam Safari Giv Fahimeh Abdollahimajd Dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development
description	Abstract COVID‐19 should be considered as a new triggering factor for autoimmune disorders like DM‐lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID‐19.
format	article
author	Mohammad Shahidi Dadras Azadeh Rakhshan Arman Ahmadzadeh Seyed Ali Hosseini Reem Diab Toktam Safari Giv Fahimeh Abdollahimajd
author_facet	Mohammad Shahidi Dadras Azadeh Rakhshan Arman Ahmadzadeh Seyed Ali Hosseini Reem Diab Toktam Safari Giv Fahimeh Abdollahimajd
author_sort	Mohammad Shahidi Dadras
title	Dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development
title_short	Dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development
title_full	Dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development
title_fullStr	Dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development
title_full_unstemmed	Dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development
title_sort	dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after sars‐cov‐2 infection: a new potential trigger for musculoskeletal autoimmune disease development
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/e356d883bbcc4adb9951d5b0c93059f0
work_keys_str_mv	AT mohammadshahididadras dermatomyositislupusoverlapsyndromecomplicatedwithcardiomyopathyaftersarscov2infectionanewpotentialtriggerformusculoskeletalautoimmunediseasedevelopment AT azadehrakhshan dermatomyositislupusoverlapsyndromecomplicatedwithcardiomyopathyaftersarscov2infectionanewpotentialtriggerformusculoskeletalautoimmunediseasedevelopment AT armanahmadzadeh dermatomyositislupusoverlapsyndromecomplicatedwithcardiomyopathyaftersarscov2infectionanewpotentialtriggerformusculoskeletalautoimmunediseasedevelopment AT seyedalihosseini dermatomyositislupusoverlapsyndromecomplicatedwithcardiomyopathyaftersarscov2infectionanewpotentialtriggerformusculoskeletalautoimmunediseasedevelopment AT reemdiab dermatomyositislupusoverlapsyndromecomplicatedwithcardiomyopathyaftersarscov2infectionanewpotentialtriggerformusculoskeletalautoimmunediseasedevelopment AT toktamsafarigiv dermatomyositislupusoverlapsyndromecomplicatedwithcardiomyopathyaftersarscov2infectionanewpotentialtriggerformusculoskeletalautoimmunediseasedevelopment AT fahimehabdollahimajd dermatomyositislupusoverlapsyndromecomplicatedwithcardiomyopathyaftersarscov2infectionanewpotentialtriggerformusculoskeletalautoimmunediseasedevelopment
_version_	1718399133426909184

Dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development

Ejemplares similares